A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery - Trial NCT06391931
Access comprehensive clinical trial information for NCT06391931 through Pure Global AI's free database. This Phase 3 trial is sponsored by Haisco Pharmaceutical Group Co., Ltd. and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 186 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Haisco Pharmaceutical Group Co., Ltd.
Timeline & Enrollment
Phase 3
Apr 07, 2024
Jan 01, 2025
Primary Outcome
Success rate of anesthesia
Summary
A multicenter, open, controlled, Phase III clinical study to evaluate the efficacy and safety
 of Cipepofol injection for general anesthesia in pediatric patients undergoing elective
 surgery
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06391931
Non-Device Trial